Emestedastat, a selective 11β-HSD1 inhibitor, demonstrates positive effects on depression in a phase 2 trial of moderate Major Depressive Disorder

Xanamem (emestedastat) - Actinogen Medical

S. Ratcliffe 1; P. Rolan 2; D. Hilt 3; T. XanaCIDD Investigator Group 4; A. Suleman 5; J. Taylor 6

Oct 10, 2025